Starting as soon as 2018, some Canadian ACMPR patients may see CBD-based medicines become more affordable, thanks to an international relationship announced in a recent press release between Canada-based licensed producer, Emblem Cannabis Corp, and Uruguayan cannabis firm, ICC.

Read more ...